Thomas Flaten
Stock Analyst at Lake Street
(3.34)
# 1,042
Out of 5,093 analysts
34
Total ratings
36.11%
Success rate
9.61%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $25.32 | +97.47% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.38 | +278.15% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.35 | +168.66% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $6.63 | +65.91% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $48.37 | +44.72% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $8.13 | +59.90% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $3.88 | +106.19% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $9.07 | +54.36% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.25 | +255.56% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $60 → $40 | $8.32 | +380.77% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $38.25 | -8.50% | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $6.10 | +31.15% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $9.26 | -2.81% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.79 | +280.71% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.68 | +135.04% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $24.74 | +1.05% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $1.42 | +101,308.45% | 2 | Nov 17, 2022 |
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $25.32
Upside: +97.47%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.38
Upside: +278.15%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.35
Upside: +168.66%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $6.63
Upside: +65.91%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $48.37
Upside: +44.72%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $8.13
Upside: +59.90%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $3.88
Upside: +106.19%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $9.07
Upside: +54.36%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.25
Upside: +255.56%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $8.32
Upside: +380.77%
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $38.25
Upside: -8.50%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $6.10
Upside: +31.15%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $9.26
Upside: -2.81%
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.79
Upside: +280.71%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.68
Upside: +135.04%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $24.74
Upside: +1.05%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $1.42
Upside: +101,308.45%